Global Bioidentical Hormones Market: Latest Trends, Opportunities and Driver

2018-04-24 13:59:38

According to a new report published by Reports Monitortitled, “Global Bioidentical Hormones Market, Growth Opportunities, Innovations and Forecast, 2018-2025,”the Bioidentical Hormones Market was valued at XX million in 2016, and is projected to reach at XX million by 2025, growing at a CAGR of XX% from 2018 to 2025. 

Bioidentical hormones act as natural hormones which can be prescribed to achieve balance level of hormones in the body. Poor diet, sedentary lifestyle, anxiety and stress are some of the factors responsible for the imbalance of hormones and create demand of the treatment. Stringent regulation of FDA for drug approval and side effect of bioidentical hormones are hampering the growth of the market. 

Advantages of bioidentical hormones treatment such as bone protection, improving energy, decreasing night sweat and improving sex drive are driving the growth of the market. Increasing population in developing countries is untapped lucrative market for the bioidentical hormones treatment. 

Request a Sample Copy @

This report provides a detailed analysis of bioidentical hormones market, which includes current industry situations such as market size, growth and demands, market outlook, major players with their key strategies such as investment, mergers and acquisitions, value chain analysis and porter’s analysis. It covers the market canvas and the growth opportunities in the coming years. The report has been made with an in-depth analysis along with important inputs from the various industry experts. The research is carried out with both extensive primary and secondary data sources supported with either bottom up or top down approach.

The global bioidentical hormones market is majorly segmented on the basis of types, dosage forms and end user. Based on the types, market is segmented into estrogens, testosterone, progesterone, thyroid and others. On the basis of dosage form the market is segmented into capsules, creams, pellets and others. On the basis of end user the market is segmented into hospitals & clinics, research institute and others.

The global Bioidentical hormones market is majorly studied across four regions: North America, Europe, Asia Pacific and LAMEA (Latin America, Middle East and Africa). Increasing geriatric population, healthcare expenditure and hormonal drug therapy awareness are driving the growth of the market. Rising population & disposal income, developing healthcare infrastructure are contributing to the growth of the bioidentical hormones market in Asia-Pacific region. Growing industrialization led to urbanization which result in adapting sedentary lifestyle, change in diet and increase stress level which led to prevalence of patient with hormonal imbalance giving rise to the market.  

The major key players operating in the market are: Abbott, AbbVie, Inc., ALLERGAN, Bayer, Novartis AG, Novo Nordisk A/S, SottoPelle, BioTE Medical, Advantage Pharmaceuticals, Inc., Full Life Wellness Center, Neuva Aesthetics, Defy Medical and Biostation.

About Garner Insights:

We at Garner provide a comprehensive analysis by providing in-depth reports of the various market verticals. Our Mission is to provide a detailed analysis of the vast markets worldwide backed by rich data. Decision makers can now rely on our well-defined data gathering methods to get the correct and accurate market forecasting along with detailed analysis.

Contact Us:

Kevin Thomas


+1 513 549 5911 (US)

+44 203 318 2846 (UK)

Email: [email protected] 

Related Press Releases